Advantagene, Inc. announced it raised $12.9 Million in an amended filing from an offering of $35 Million

Jul 13, 2016•about 9 years ago

Amount Raised

$12.9 Million

AuburndaleBiotechnology

Company Information

Company

Advantagene, Inc.

Location

440 LEXINGTON STREET

Auburndale, Massachusetts, United States

About

Advantagene, a biotechnology company, develops and commercializes cancer immunotherapy drugs.

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech